Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel vs Cilostazol in Ischemic Stroke
NCT06242132Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jun 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in ischemic stroke comparing Clopidogrel Arm with Cilostazol Arm (2 arms). Primary endpoints: Rate of new stroke at 90 days and Rate of drug hemorrhagic complications at 90 days. Started Jun 2022; status: completed.
02
Drugs
clopidogrelcilostazol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06242132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06242132.